Efficacy and Hematologic Toxicity of Salvage Chemotherapy Following Stem Cell-Supported High-Dose Chemotherapy in Women with Recurrent Ovarian Cancer

By Cook S.   Penson R.   Duska L.   Nikrui N.   Goodman A.   Fuller A.   Seiden M.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 48-54

Elsevier

Access to resources Recommend Favorite

Very High-dose Chemotherapy with Autologous Peripheral Stem Cell Support in Advanced Ovarian Cancer

By Benedetti-Panici P.   Greggi S.   Scambia G.   Salerno M.G.   Baiocchi G.   Laurelli G.   Menichella G.   Pierelli L.   Foddai M.L.   Serafini R.   Bizzi B.   Mancuso S.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1987-1992

Elsevier

Access to resources Recommend Favorite

The Prognostic Significance of Peritoneal Seeding and Size of Postsurgical Residual in Patients with Stage III Epithelial Ovarian Cancer Treated with Surgery, Chemotherapy, and High-Dose Radiotherapy

By Kapp K.S.   Kapp D.S.   Poschauko J.   Stucklschweiger G.F.   Hackl A.   Pickel H.   Petru E.   Winter R.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 400-407

Elsevier

Access to resources Recommend Favorite

Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

By Schilder R.J.   Brady M.F.   Spriggs D.   Shea T.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 3-8

Academic Press

Access to resources Recommend Favorite